Table 2. Analysis of the association between lncRNA AC079630.4 expression and clinicopathological features of lung cancer based on dataset GSE30219.
| Variables | Low expression (n=147) | High expression (n=146) | P value |
| Age (years) | 62.5 ± 1.10 | 63.5 ± 0.77 | 0.280 |
| Gender | |||
| Male | 122 (83.0%) | 128 (87.7%) | 0.258 |
| Female | 25 (17.0%) | 18 (12.3%) | |
| T stage | |||
| T1 | 59 (41.8%) | 107 (73.3%) | <0.001 |
| T2 | 43 (30.5%) | 26 (17.8%) | |
| T3 | 22 (15.6%) | 9 (6.2%) | |
| T4 | 17 (12.1%) | 4 (2.7%) | |
| N stage | |||
| N0 | 78 (53.8%) | 120 (82.2%) | <0.001 |
| N1 | 34 (23.4%) | 19 (13.0%) | |
| N2 | 23 (15.9%) | 7 (4.8%) | |
| N3 | 10 (6.9%) | 0 (0.0%) | |
| M stage | |||
| M0 | 138 (95.2%) | 144 (99.3%) | 0.031 |
| M1 | 7 (4.8%) | 1 (0.7%) |